Screener
Charles River Laboratories CRL Q3 2025 earnings
Reported November 5, 2025 · Before market open
Revenue$1.0BBeat by $17.7M
EPS$2.43Beat by $0.11
Revenue estimate$987.2M
EPS estimate$2.32
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$958.5M
EPS estimate$2.96
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Charles River Laboratories report Q3 2025 earnings?
- Charles River Laboratories (CRL) reported Q3 2025 earnings on November 5, 2025 before market open.
- What were Charles River Laboratories's Q3 2025 revenue and EPS?
- Charles River Laboratories reported revenue of $1.0B and eps of $2.43 for Q3 2025.
- Did Charles River Laboratories beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $987.2M by $17.7M. EPS beat the consensus estimate of $2.32 by $0.11.
- How did Charles River Laboratories's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 0.5% from $1.0B a year earlier and eps declined 6.2% from $2.59.
- Where can I find Charles River Laboratories's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001100682-25-000041) and the 10-Q periodic report (0001100682-25-000043) directly on SEC EDGAR. The filing index links above go to sec.gov.
